We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA SENDS MIXED SIGNALS ON COVERAGE OF FOREIGN DRUGS
FDA SENDS MIXED SIGNALS ON COVERAGE OF FOREIGN DRUGS
April 13, 2004
Despite public pronouncements that the FDA will prosecute health plans that cover the cost of drugs bought outside the U.S., the agency allegedly is saying the opposite to insurers behind closed doors.